Agreement signedPublished 8 Mar 2022

Scion /
BioLargo

Scion to receive SkinDisc IP from BioLargo

Terms
Not stated
Stage
Agreement signed
Source · 8 Mar 2022
01 / BuyerScion
02 / TargetBioLargo
01

What happened

BioLargo and Clyra Medical agreed to transfer the Scion IP back to Scion under an agreement fully executed on March 3, 2022.

In exchange, Scion agreed to accept 2,000,000 BioLargo common shares, forgive the outstanding principal and interest on the Scion Promissory Note, and return its Clyra common stock.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Scion to receive SkinDisc IP from BioLargo

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Agreement signed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.